Professional Documents
Culture Documents
Reasoning. (Read
Technical
commentary).
Short term Trend:
Bullish.
Medium Term
Trend: Bearish.
For the Traders: BUY
For Aggressive
Traders: BUY
Support: 3400-33203250
Resistance-35503600-3700
Duration: 4-5 Days
Recommendation:On the basics of technical
and Fundamental
analysis we are
Recommending to buy
Sybean Feb above (3540)
with the Stop Loss of
3450 for the Target of
3630 and 3700.
CARDAMOM JAN
Cardamom Jan: Prices fired previous couple of session from the low of 905, reached high 972.80
STOCK: Cardamom
Jan
in previous day and prices, rebounded firmly from the resistance of 976.90 and later closed at
975. Cardamom futures slumped on long liquidation trigged by strong availability. Cardamom
Call: SELL
CMP: 975
futures are expected to remain weak on strong arrivals and any upside is not sustainable
considering the present scenario. Cardamom as weak domestic market demand, high stocks and
Initiation Level:
Around 980
Book Profit (Level 1):
960
bearishness in International markets kept pressure on the domestic market sentiments. Last few
days added further to the buying atmosphere. Prices are however above at strong psychological
Support level of 910 for Feb contract. For the week, any break below the moving average 200
SMA support of 910 could see downside bias towards 884 followed by 860. Analysts said
offloading of positions by speculators, driven by sufficient stocks position in the spot markets on
increased arrivals from producing belts, mainly pulled down cardamom prices in futures trade.
DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to
be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion.
Users have the right to choose the product/s that suits them the most. Sincere efforts have been
made to present the right investment perspective. The information contained herein is based on
analysis and up on sources that we consider reliable.
Entering our site means that you have read, understood and agreed to everything that is written and implied in this
disclaimer note. RESEARCH is published solely for informational purposes and must in no way be construed as investment
advice for a specific individual. The information and views in this website & all the services we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the
product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information
contained herein is based on analysis and on sources that we consider reliable. We, however, do
not vouch for the accuracy or the completeness thereof. This material is for personal information
and we are not responsible for any loss incurred due to it & take no responsibility whatsoever for
any financial profits or loss which may arise from the recommendations above.